Current therapies for neuropathic pain are generally symptomatic and possess several side effects, limiting their pro- longed usage. Thus, it is urgent to develop novel and safe candidates for the management of this chronic condition. For this purpose, we investigated the analgesic effect of a Zingiber officinale Roscoe extract (ZOE), standardized in gingerols and terpenes, in a mice model of peripheral neuropathy. We also explored the mechanism of action of ZOE and its main constituents using an in vitro model of neuroinflammation. HDAC has a pivotal role in the development of neuropathic pain, thus, we also investigated the ability of ZOE and its constituents to inhibit HDAC isoforms expression and activity. METHODS: Peripheral mono-neuropathy was induced in mice, by spared nerve injury (SNI). The analgesic effect of ZOE after oral administration was assessed by measuring mechanical and ther- mal allodynia in SNI mice. The mechanism of ac- tion of ZOE and its main constituents was inves- tigated using spinal cord samples and an in vitro model of neuroinflammation by ELISA, western blotting and immunofluorescence techniques. RESULTS: Oral administration of ZOE 200 mg kg-1 ameliorated mechanical and thermal allo- dynia in SNI mice, with a rapid and a long-last- ing effect without altering locomotor activity. In BV2 cells and spinal cord samples, ZOE modu- lated MAPKs activation and HDAC expression. The activity on HDAC was found to be selective for class I isoforms and mainly mediated by the terpenes fraction. The anti-inflammatory effect of ZOE and its constituents led to a neuroprotective effect on inflammation-impaired SH-SY5Y cell viability. CONCLUSIONS: The oral administration of ZOE attenuated SNI-induced neuropathic pain symp- toms by reducing spinal neuroinflammation, suggesting ZOE as a novel and interesting candidate for the management of neuropathic pain.
Borgonetti, V., Governa, P., Biagi, M., Pellati, F., Galeotti, N. (2021). ZINGIBER OFFICINALE ROSCOE RHIZOME EXTRACT ALLEVIATES NEUROPATHIC PAIN IN MICE BY REDUCING NEUROINFLAMMATION THROUGH THE INHIBITION OF CLASS I HDAC ISOFORMS. In 3 (pp.49-50). Edra.
ZINGIBER OFFICINALE ROSCOE RHIZOME EXTRACT ALLEVIATES NEUROPATHIC PAIN IN MICE BY REDUCING NEUROINFLAMMATION THROUGH THE INHIBITION OF CLASS I HDAC ISOFORMS
Vittoria Borgonetti;
2021-01-01
Abstract
Current therapies for neuropathic pain are generally symptomatic and possess several side effects, limiting their pro- longed usage. Thus, it is urgent to develop novel and safe candidates for the management of this chronic condition. For this purpose, we investigated the analgesic effect of a Zingiber officinale Roscoe extract (ZOE), standardized in gingerols and terpenes, in a mice model of peripheral neuropathy. We also explored the mechanism of action of ZOE and its main constituents using an in vitro model of neuroinflammation. HDAC has a pivotal role in the development of neuropathic pain, thus, we also investigated the ability of ZOE and its constituents to inhibit HDAC isoforms expression and activity. METHODS: Peripheral mono-neuropathy was induced in mice, by spared nerve injury (SNI). The analgesic effect of ZOE after oral administration was assessed by measuring mechanical and ther- mal allodynia in SNI mice. The mechanism of ac- tion of ZOE and its main constituents was inves- tigated using spinal cord samples and an in vitro model of neuroinflammation by ELISA, western blotting and immunofluorescence techniques. RESULTS: Oral administration of ZOE 200 mg kg-1 ameliorated mechanical and thermal allo- dynia in SNI mice, with a rapid and a long-last- ing effect without altering locomotor activity. In BV2 cells and spinal cord samples, ZOE modu- lated MAPKs activation and HDAC expression. The activity on HDAC was found to be selective for class I isoforms and mainly mediated by the terpenes fraction. The anti-inflammatory effect of ZOE and its constituents led to a neuroprotective effect on inflammation-impaired SH-SY5Y cell viability. CONCLUSIONS: The oral administration of ZOE attenuated SNI-induced neuropathic pain symp- toms by reducing spinal neuroinflammation, suggesting ZOE as a novel and interesting candidate for the management of neuropathic pain.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
https://hdl.handle.net/11365/1289083
Attenzione
Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo
